The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial
Titel:
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial
Auteur:
van Bommel, Erik J.M. Muskiet, Marcel H.A. van Baar, Michaël J.B. Tonneijck, Lennart Smits, Mark M. Emanuel, Anna L. Bozovic, Andrea Danser, A.H. Jan Geurts, Frank Hoorn, Ewout J. Touw, Daan J. Larsen, Emil L. Poulsen, Henrik E. Kramer, Mark H.H. Nieuwdorp, Max Joles, Jaap A. van Raalte, Daniël H.